By Dr Mark Enea Montebello

Conference Papers

Heijstee N; Black E; Black E; Demirkol A; Mills L; Deacon RM; Mammen K; Dunlop AJ; Ezard N; Montebello M; Reid D; Childs S; Lintzeris N, 2021, 'WHO WE ARE HELPING: DESCRIBING DEMOGRAPHIC, HEALTH AND SOCIAL FACTORS ASSOCIATED WITH PRINCIPAL DRUG OF CONCERN, ALCOHOL USE AND ALCOHOL-RELATED HARMS, IN THE AUSTRALIAN ALCOHOL AND OTHER DRUG TREATMENT-SEEKING POPULATION', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S79 - S79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhardwaj AK; Allsop DJ; Rooney K; Arnold J; Bruno R; Montebello M; Gugusheff J; Kerley W; Murnion BP; Haber PS; McGregor IS; Lintzeris N, 2017, 'RANDOMISED CONTROLLED TRIAL OF DAILY AEROBIC EXERCISE FOR INPATIENT CANNABIS WITHDRAWAL', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Montebello ME, 2003, 'A pilot study of mirtazapine and psychotherapy in cannabis dependency', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, BLACKWELL PUBLISHING ASIA, pp. A2 - A2, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186635700007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Black E; Deacon RM; Mills L; Mammen K; Dunlop A; Ezard N; Montebello M; Bruno R; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried K; Cretikos M; Lintzeris N, 2021, 'Starting treatment in public drug and alcohol services in New South Wales: What can electronic medical records tell us about amphetamine type stimulant use?', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Conference Abstracts

Mills L; Mammen K; Deacon RM; Black E; Montebello M; Bruno R; Dunlop AJ; Ezard N; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried KJ; Lintzeris N, 2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Black E; Deacon RM; Mills L; Dunlop A; Ezard N; Bruno R; Shakeshaft A; Farrell M; Holmes J; Cretikos MA; Montebello M; Reid D; Childs S; Siefried KJ; Mammen K; Lintzeris N, 2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Black E; Deacon RM; Mills L; Dunlop AJ; Ezard N; Bruno R; Shakeshaft A; Farrell M; Holmes J; Cretikos MA; Montebello M; Reid D; Childs S; Siefried KJ; Mammen K; Lintzeris N, 2019, 'CHARACTERISTICS AND TREATMENT OUTCOMES OF THE DRUG TREATMENT POPULATION IN NEW SOUTH WALES: FOCUS ON AMPHETAMINE TYPE STIMULANTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Mills L; Dunlop AJ; Copeland J; McGregor I; Bruno R; Gugusheff J; Nghi P; Montebello M; Chan T; Kirby A; Hall M; Bhardwaj A; Jefferies M; Luksza J; Shanahan M; Kevin R; Allsop D, 2019, 'EFFICACY OF NABIXIMOLS IN REDUCING FREQUENCY OF CANNABIS USE THREE MONTHS AFTER TREATMENT CESSATION: RESULTS FROM A RANDOMISED CONTROLLED TRIAL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S66 - S67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Allsop D; Bhardwaj A; Mills L; Dunlop AJ; Copeland J; McGregor I; Bruno R; Gugusheff J; Phung N; Montebello M; Chan T; Kirby A; Hall M; Jefferies M; Luksza MJ; Shanahan M; Kevin R, 2018, 'FINDINGS OF A PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIAL OF NABIXIMOLS IN THE TREATMENT OF CANNABIS DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S45 - S46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Allsop D; Mills L; Bhardwaj A; Dunlop AJ; Copeland J; McGregor I; Bruno R; Gugusheff J; Montebello M; Silsbury C; Jackson M; Jefferies M, 2018, 'TREATING COMORBIDITIES IN CANNABIS DEPENDENT PATIENTS WITH NABIXIMOLS: FINDINGS OF A PLACEBO CONTROLLED RANDOMISED CONTROLLED TRIAL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S46 - S46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yee J; Dore GJ; Hanson J; Iser D; Danta M; Shaw D; Read P; Balcomb A; Post J; Faros J; Montebello M; Collie P; Hallinan R; Cooper L; Marks P; Hajarizadeh B; Matthews GV, 2018, 'High efficacy of HCV therapy following universal DAA access in Australia: the REACH-C cohort', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 54 - 54, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page